bioMérieux

French company specialised in in vitro diagnostics

ISIN FR0010096479 LEI 549300AK8Y0LBIQ4T071
Follow bioMérieux Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2025 EUR · IFRS
Revenue, last year €4.1B +2.3% vs prior year
Net income €397.5M −8% vs prior year
EPS, diluted -
Operating cash flow €788.4M +18.1% vs prior year
Revenue by fiscal year
€3.1B
€3.4B
€3.6B
€3.7B
€4B
€4.1B
FY20 FY21 FY22 FY23 FY24 FY25

Source: ESEF annual reports · latest filing

The long view

Fiscal years as reported · ESEF annual reports, IFRS
Revenue and net income7 fiscal years
  • Revenue
  • Net income
€0€2B€4B€6BFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25€4.1B€397.5M
FY24€4B€432.2M
FY23€3.7B€357.6M
FY22€3.6B€452.4M
FY21€3.4B€601.1M
FY20€3.1B€404.4M
FY19€2.7B€272.8M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2556.7%12.8%9.8%
FY2455.7%14.8%10.9%
FY2356%11.9%9.7%
FY2256%16.4%12.6%
FY2158.2%23.2%17.8%
FY2056.2%17.7%13%
FY1954.8%13.9%10.2%
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
€0€100M€200M€300MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearDividendsBuybacks
FY25€106.1M€18.2M
FY24€100.2M€37.6M
FY23€100.2M€12.7M
FY22€101.2M€157.2M
FY21€73.1M€3.8M
FY20€22.5M€18.4M
FY19€41.3M€0